FDA toughens up on medical devices

The FDA asked several medical-device makers to justify the safety and effectiveness of products already on the market, as part of a move to require tougher evidence standards before products can be sold. The requests for data affect Johnson & Johnson, Medtronic and Abiomed, among others. Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.